Skip to main content

Research Repository

Advanced Search

Vitamin D and calcium supplementation in women undergoing pharmacological management for postmenopausal osteoporosis: a level I of evidence systematic review

Migliorini, Filippo; Maffulli, Nicola; Colarossi, Giorgia; Filippelli, Amelia; Memminger, Michael; Conti, Valeria

Authors

Filippo Migliorini

Nicola Maffulli

Giorgia Colarossi

Amelia Filippelli

Michael Memminger

Valeria Conti



Abstract

The present systematic review investigates whether different doses of vitamin D and calcium supplementation in women with postmenopausal osteoporosis undergoing antiresorptive therapy have an association with BMD (spine, hip, femur neck), serum markers of osteoporosis (bone-ALP, NTX, CTX), the rate of pathological vertebral and non-vertebral fractures, adverse events, and mortality. This systematic review was conducted according to the PRISMA 2020 guidelines. PubMed, Google Scholar, Embase, and Scopus databases were accessed in September 2024. All randomised clinical trials (RCTs) comparing two or more treatments for postmenopausal osteoporosis supplemented with vitamin D and/or calcium were accessed. Only studies that indicated daily vitamin D and/or calcium supplementation doses were accessed. Data from 37 RCTs (43,397 patients) were retrieved. Patients received a mean of 833.6 ± 224.0 mg and 92.8 ± 228.7 UI of calcium and vitamin D supplementation, respectively. The mean length of the follow-up was 25.8 ± 13.3 months. The mean age of the patients was 66.4 ± 5.6 years, and the mean BMI was 25.2 ± 1.6 kg/m2. There was evidence of a statistically significant negative association between daily vitamin D supplementation and gastrointestinal adverse events (r = − 0.5; P = 0.02) and mortality (r = − 0.7; P = 0.03). No additional statistically significant associations were evidenced. In postmenopausal women who undergo antiresorptive treatment for osteoporosis, vitamin D was associated with a lower frequency of gastrointestinal adverse events and mortality. Calcium supplementation did not evidence an association with any of the endpoints of interest. Level of evidence Level I, systematic review of RCTs.

Citation

Migliorini, F., Maffulli, N., Colarossi, G., Filippelli, A., Memminger, M., & Conti, V. (in press). Vitamin D and calcium supplementation in women undergoing pharmacological management for postmenopausal osteoporosis: a level I of evidence systematic review. European Journal of Medical Research, 30(1), Article 170. https://doi.org/10.1186/s40001-025-02412-x

Journal Article Type Article
Acceptance Date Feb 26, 2025
Online Publication Date Mar 14, 2025
Deposit Date Mar 18, 2025
Publicly Available Date Mar 18, 2025
Journal European Journal of Medical Research
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 30
Issue 1
Article Number 170
DOI https://doi.org/10.1186/s40001-025-02412-x
Keywords Calcium, Supplementation, Vitamin D, Postmenopausal, Osteoporosis
Public URL https://keele-repository.worktribe.com/output/1107312
Publisher URL https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-02412-x

Files

Vitamin D and calcium supplementation in women undergoing pharmacological management for postmenopausal osteoporosis: a level I of evidence systematic review (1.1 Mb)
Archive

Licence
https://creativecommons.org/licenses/by/4.0/

Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/

Copyright Statement
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.






You might also like



Downloadable Citations